发明名称 Multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
摘要 A method of treating blood withdrawn from patient including: simultaneously withdrawing blood and infusing withdrawn blood from and to the patient by flowing the withdrawn blood through an extracorporeal dialysis circuit including a dialyzer having a semi-permeable dialysis membrane and a dialysate side adjacent the membrane; feeding a dialysate containing 1 to 5 mM total calcium and 2 to 8 mM citrate to the dialysate side of the dialyzer, and introducing an anticoagulation fluid including at least 8 mM citrate into the arterial blood line.
申请公布号 US9486570(B2) 申请公布日期 2016.11.08
申请号 US201414553417 申请日期 2014.11.25
申请人 Gambro Lundia AB 发明人 Sternby Jan
分类号 A61M1/16;A61K33/00;A61M1/36;A61K31/191;A61K31/194;A61K31/7004;A61K33/06;A61K33/10;A61K33/14;A61K33/20;A61K33/42 主分类号 A61M1/16
代理机构 Nixon & Vanderhye P.C. 代理人 Nixon & Vanderhye P.C.
主权项 1. A multipart fluid system for treating extracorporeal blood comprising: an extracorporeal blood passage including an inlet configured to receive blood withdrawn from a patient and an outlet configured to discharge treated blood to be infused into the patient; a pump configured to be coupled to the extracorporeal blood passage to simultaneously withdraw blood from the patient, pass withdrawn blood through the blood passage and infuse treated blood into the patient; a first fluid source configured to be in fluid communication with the extracorporeal blood passage, wherein the first fluid source contains an anticoagulation fluid including at least 8 mM citrate, and a second fluid source configured to be in fluid communication with the extracorporeal blood passage, wherein the second fluid source contains a blood treatment fluid comprising 2-8mM citrate and 1 to 5 mM total calcium.
地址 Lund SE